Tune into episode 50 of the Benchtop Bios Podcast Series featuring Dr. Graeme Smith, Chief Scientific Officer of èßäAV³ÉÈË, as he discusses the PARP inhibitor drug, Lynparza® and two new DDR-targeting, clinical stage assets developed at èßäAV³ÉÈË.
Listen here: